Celerion Holdings, Inc.

Celerion Holdings, Inc. is a leading provider of clinical research services, dedicated to advancing the development of new therapeutics and medical devices. Established with a vision to enhance patient care through innovative research, Celerion plays a pivotal role in the pharmaceutical and biotechnology industries.

With a commitment to quality and integrity, Celerion offers a comprehensive range of services including:

• Clinical Trial Management: Expert management of clinical trials from Phase I to Phase IV.
• Bioanalytical Services: State-of-the-art laboratories providing accurate and reliable bioanalytical testing.
• Regulatory Consulting: Guidance through the complex regulatory landscape to ensure compliance and expedite approvals.
• Patient Recruitment: Innovative strategies to recruit and retain participants for clinical studies.

Headquartered in the UK, Celerion is strategically positioned to serve clients globally, leveraging its extensive network of clinical sites and experienced professionals. The company prides itself on its scientific expertise and operational excellence, ensuring that every project is executed with precision and care.

Celerion’s mission is to support the healthcare community by delivering high-quality data that accelerates the development of safe and effective therapies. By fostering strong partnerships with clients, Celerion aims to contribute to the advancement of medical science and improve patient outcomes worldwide.